Thursday, 15 November 2018

WHO plans collaboration for developing Nipah vaccine

01 June 2018 | News

According to WHO, the roadmap prioritises the development of countermeasures (diagnostics, therapeutics and vaccines) that need to be taken by Nipah-affected countries.

Image credit- ccentre.com

Image credit- ccentre.com

To tackle the Nipah Virus and to develop a roadmap to do the same, the Center for Infectious Disease Research and Policy (CIDRAP) at the University of Minnesota, with support from the Wellcome Trust, will collaborate with the World Health Organization (WHO). This will facilitate the collaborative development of a draft ‘Nipah R&D Roadmap’.

Nipah Virus is one of the pathogens in the WHO R&D Blueprint list of epidemic threats that need urgent research and development action. According to WHO, the roadmap prioritises the development of countermeasures (diagnostics, therapeutics and vaccines) that need to be taken by Nipah-affected countries. It is the result of extensive consultations with the Nipah R&D roadmap taskforce, national and international experts and other key stakeholders.

The first Blueprint list of priority diseases was released in December 2015, and the list was reviewed last in February 2018. The disease’s potential to cause a public health emergency and the absence of efficacious drugs and/or vaccines helps the experts determine if there is an urgent need for accelerated research and development for these diseases.

Comments

× Your session has been expired. Please click here to Sign-in or Sign-up
   New User? Create Account

Click Here!




Survey Box

Will the health insurance sector receive benefits from Ayushman Bharat?

× Please select an option to participate in the poll.
Processing...   View poll results   More polls

× You have successfully cast your vote.
{{ optionDetail.option }}{{ optionDetail.percentage }}%
{{ optionDetail.percentage }}% Complete
More polls